AZD9793
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD9793, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours [Phase 1, Phase 2]